BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
- Resource Type
- Authors
- Michael Buerke; Martin Russ; Henning Lemm; K Huber; Alexander Geppert; Roland Prondzinsky; Karl Werdan
- Source
- Critical Care
- Subject
- Lv function
medicine.medical_specialty
medicine.drug_class
business.industry
Cardiogenic shock
Organ dysfunction
Critical Care and Intensive Care Medicine
medicine.disease
Internal medicine
Heart failure
Shock (circulatory)
Poster Presentation
cardiovascular system
medicine
Natriuretic peptide
Cardiology
In patient
cardiovascular diseases
Myocardial infarction
medicine.symptom
business
hormones, hormone substitutes, and hormone antagonists
- Language
- ISSN
- 1364-8535
B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are routine diagnostic and monitoring markers in patients with heart failure. LV function and prognosis of these patients have been shown to be reflected by BNP and NT-proBNP levels. However, in patients with cardiogenic shock after myocardial infarction, the relationship and relevance of these markers has not been elucidated.